Kontafarma China Holdings Limited (HKG:1312)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.0300
-0.0010 (-3.23%)
Jul 31, 2026, 3:58 PM HKT

Kontafarma China Holdings Financials Overview

Millions HKD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
914.71914.71897.52809.11894.06803.27
Revenue Growth
2.58%1.92%10.93%-9.50%11.30%-20.40%
Gross Profit
513.64513.64516.16471.29506.22396.18
Operating Income
-44.9-44.9-45.23-92.33-84.41-97.71
Net Income
-427.85-427.85-75.54-28.84-41.55-15.05
Earnings Per Share
-0.08-0.08-0.01-0.01-0.01-0.00
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Pharmaceutical Business
716.97716.97682.09607.13722.9641.99
Fitness Business
197.74197.74215.44201.98171.16161.28
Total
914.71914.71897.52809.11894.06803.27

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
66.0666.0690.5987.66142.6183.96
Total Debt
203.68203.68297.19333.82590.72728.95
Net Cash (Debt)
-137.62-137.62-206.6-246.16-448.13-544.99
Net Cash Growth
------
Net Cash Per Share
-0.02-0.02-0.04-0.04-0.08-0.10

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
76.6876.6847.0537.12-2.1775.07
Capital Expenditures
-23.52-23.52-13.64-23.92-51.68-67.19
Free Cash Flow
53.1553.1533.4113.2-53.847.88
Free Cash Flow Growth
65.42%59.10%153.17%---84.57%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
56.15%56.15%57.51%58.25%56.62%49.32%
Operating Margin
-4.91%-4.91%-5.04%-11.41%-9.44%-12.16%
Pretax Margin
-49.71%-49.71%-10.92%-5.43%-13.17%-6.78%
Profit Margin
-46.77%-46.77%-8.42%-3.56%-4.65%-1.87%
FCF Margin
5.81%5.81%3.72%1.63%-6.02%0.98%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
3.153.054.3515.25-34.77
PS Ratio
0.180.180.160.250.280.34